Figure 1
From: Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
Patients who responded to ezatiostat under-expressed miR-129 (A) and over-expressed miR-155 (B).
Figure 1 | Journal of Hematology & Oncology